Q4 2024 Earnings Call Transcript February 12, 2025 Operator: Good morning. My name is Jennifer and I will be your conference ...

In the fourth quarter, lower sales of BIIB's multiple sclerosis drugs and Spinraza are likely to have been offset by revenues from new drugs.

I was in Brazil last year and there are quite a number of patients ... one that nobody is really doing so much research in a broad area of modalities as Biogen but the other is they are extremely ...

Q4 2024 Earnings Conference Call February 12, 2025 8:30 AM ETCompany ParticipantsTim Power - Head of IRChris Viehbacher ...

Silvio Borges dos Santos Fachim assume a liderança do Departamento Jurídico da farmacêutica, trazendo quase 20 anos de ...

Em abril, o CEO do Grupo SBF será Gustavo Furtado, vindo da Centauro e que sucede Pedro Zemel. Gustavo Furtado. Foto: ...

Also in today’s newsletter, Foxconn confirms interest in Nissan stake and Disney cuts diversity category from executive pay ...

EU Mid-Market Update: Another session with volatility weighted to second half of day as market waits for first US CPI reading ...